hrcak mascot   Srce   HID

Prethodno priopćenje
https://doi.org/10.2478/acph-2021-0016

Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies

SAFA DAOUD ; Department of Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan
SHADA J. ALABED ; Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman, Jordan
LINA A. DAHABIYEH ; Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman, Jordan

Puni tekst: engleski, pdf (4 MB) str. 163-174 preuzimanja: 58* citiraj
APA 6th Edition
DAOUD, S., ALABED, S.J. i DAHABIYEH, L.A. (2021). Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies . Acta Pharmaceutica, 71 (2), 163-174. https://doi.org/10.2478/acph-2021-0016
MLA 8th Edition
DAOUD, SAFA, et al. "Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies ." Acta Pharmaceutica, vol. 71, br. 2, 2021, str. 163-174. https://doi.org/10.2478/acph-2021-0016. Citirano 05.12.2020.
Chicago 17th Edition
DAOUD, SAFA, SHADA J. ALABED i LINA A. DAHABIYEH. "Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies ." Acta Pharmaceutica 71, br. 2 (2021): 163-174. https://doi.org/10.2478/acph-2021-0016
Harvard
DAOUD, S., ALABED, S.J., i DAHABIYEH, L.A. (2021). 'Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies ', Acta Pharmaceutica, 71(2), str. 163-174. https://doi.org/10.2478/acph-2021-0016
Vancouver
DAOUD S, ALABED SJ, DAHABIYEH LA. Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies . Acta Pharm. [Internet]. 2021 [pristupljeno 05.12.2020.];71(2):163-174. https://doi.org/10.2478/acph-2021-0016
IEEE
S. DAOUD, S.J. ALABED i L.A. DAHABIYEH, "Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies ", Acta Pharmaceutica, vol.71, br. 2, str. 163-174, 2021. [Online]. https://doi.org/10.2478/acph-2021-0016

Ključne riječi
COVID-19; main protease; pharmacophore; structure-based modeling; docking study; remdesivir; repurposing

Hrčak ID: 238733

URI
https://hrcak.srce.hr/238733

Posjeta: 140 *